SparingVision logo

SparingVision jobs and careers

Paris, Île-de-France, France

About SparingVision

SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal degeneration.

Founded in 2016 by Jose Alain Sahel and Thierry Léveillard.

Founded
2016
Employees
11 to 50
Total funding
$119.5M
Headquarters
Paris

Leadership

The top of SparingVision's org chart, with how many people report into each leader.

SBPhoto of Stéphane Boissel

Stéphane Boissel

President & CEO

26 reports

KSPhoto of Kali Stasi

Kali Stasi

Chief Medical Officer

10 reports

MGPhoto of Mehdi Gasmi

Mehdi Gasmi

Chief Operating Officer

5 reports

MUPhoto of Marie Uguen

Marie Uguen

SVP, Regulatory Affairs & QA

2 reports

AGPhoto of Anjeza Gjino

Anjeza Gjino

Interim Chief Financial Officer

2 reports

RKPhoto of Ryan Klimczak

Ryan Klimczak

VP, Intellectual Property

1 report

RGPhoto of Rajiv Gangurde

Rajiv Gangurde

CTO

Board

PSPhoto of Paul Sieving

Paul Sieving

Scientific Advisor

LAPhoto of Laurent Arthaud

Laurent Arthaud

Director

MTPhoto of Masayo Takahashi

Masayo Takahashi

Clinical Advisor

BRPhoto of Botond Roska

Botond Roska

Scientific Advisor

OSPhoto of Owen Smith

Owen Smith

Director

JCPhoto of Jeanne Cunicelli

Jeanne Cunicelli

Director

Jobs at SparingVision

No open positions right now. Explore more companies on TheJobsMap.